Interviews/Contributions Investor Insights: Louis Cannon, MD of BioStar Capital – why were different (part 1) Share by Ken Dropiewski on February 28, 2024 More in Interviews/Contributions: Investor Insights: Jan and Jeff from Arboretum Share Their Outlook on MedTech Investing October 2, 2026 Investor Insights: Arboretum – Stage of investment September 24, 2026 Investor Insights – Jeff Terrell and Jan Garfinkle of Aboretum: What Do They Look for and How to Best Prepare for Them September 14, 2026 Share this story Facebook Twitter LinkedIn